Epizyme, Inc. (45) | License Agreements (2)
- Amendment No. 1 to License Agreement between the Company and HUTCHMED Group Investment Limited (formerly known as Hutchison China MediTech Investment Limited) (Filed With SEC on August 9, 2022)
- License Agreement dated August 7, 2021 between the Registrant and Hutchison China MediTech Investment Limited (Filed With SEC on November 9, 2021)
